Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. ALVO
ALVO logo

ALVO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ALVO News

Alvotech Completes $165 Million Public Offering and Private Placement

2d agoNewsfilter

Alvotech Closes $26.07 Million Public Offering

2d agoNASDAQ.COM

Alvotech Raises $152 Million Through Public Offering and Private Placement

4d agoNASDAQ.COM

Alvotech Announces Public Offering and Private Placement to Raise $152M

4d agoseekingalpha

Alvotech Prices Public Offering of 22,666,667 Shares at $3.75 Each

4d agoNewsfilter

Alvotech Prices Public Offering of 22.67 Million Shares

4d agoYahoo Finance

Alvotech Launches Underwritten Public Offering

4d agoseekingalpha

Teva Pharmaceutical's Recovery: Challenges and Opportunities in Biosimilars

Jun 12 2026Fool

Tango Therapeutics Shares Surge Over 50% on Positive Trial Data

Jun 09 2026NASDAQ.COM

Alvotech's AVT16 Biosimilar Application Accepted by FDA

Jun 08 2026seekingalpha

Alvotech Submits BLA for AVT16 Biosimilar to Entyvio

Jun 08 2026Newsfilter

Veru Shares Surge 88% on Novo Nordisk Collaboration

Jun 05 2026NASDAQ.COM

Alvotech Resubmits U.S. Biosimilar Applications for AVT05 and AVT06

Jun 04 2026seekingalpha

Alvotech Resubmits Biologics License Applications for Biosimilars

Jun 04 2026NASDAQ.COM

Alvotech Resubmits Biologics License Applications for Biosimilars

Jun 04 2026Newsfilter

Alvotech Successfully Holds 2026 Annual General Meeting

Jun 03 2026Newsfilter